𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antitumor effects of the cytotoxic luteinizing hormone–releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

✍ Scribed by Carsten Gründker; Peter Völker; Frank Griesinger; Annette Ramaswamy; Attila Nagy; Andrew V. Schally; Günter Emons

Book ID
114487880
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
94 KB
Volume
187
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted cytotoxic analog of luteinizing
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice
✍ Kopp�n, Miklos; Nagy, Attila; Schally, Andrew V.; Plonowski, Artur; Halmos, G�bo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

## Background: Receptors for luteinizing hormone-releasing hormone (lh-rh) found in prostate cancers might be used for targeting of chemotherapeutic agents. doxorubicin derivative 2-pyrrolinodoxorubicin (an-201) can be linked to carrier analog [d-lys6]lh-rh to form the targeted cytotoxic analog of

Growth-inhibitory effects of luteinizing
Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice
✍ Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 2 views

Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for